High prevalence of hyperhomocysteinemia in Chinese adults is associated with low folate, vitamin B-12, and vitamin B-6 status

Journal of Nutrition

Volumn 137, Issue 2, 2007, Pages 407-413

  Hao, Ling ^a   Ma, Jing ^b   Zhu, Jianghui ^a   Stampfer, Meir J ^b,c   Tian, Yihua ^a   Willett, Walter C ^b,c   Li, Zhu ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; AUTUMN; BLOOD SAMPLING; CHINESE; DISEASE PREDISPOSITION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; RURAL AREA; SEASONAL VARIATION; SPRING; URBAN AREA;

EID: 33846840534     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.2.407     Document Type: Article

References (40)

1. Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, Wright JD, Johnson CL. Serum total homocysteine concentrations in the Third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med. 1999;131:331-9.
2. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. BMJ. 1998;316:894-8.
3. McKinley MC, McNulty H, Mc Partlin J, Strain JJ, Pentieva K, Ward M, Weir DG, Scott JM. Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am J Clin Nutr. 2001;73:759-64.
4. Mansoor MA, Kristensen O, Hervig T, Bates CJ, Pentieva K, Vefring H, Osland A, Berge T, Drablos PA. Plasma total homocysteine response to oral doses of folic acid and pyridoxine hydrochloride (vitamin B6) in healthy individuals. Oral doses of vitamin B6 reduce concentrations of serum folate. Scand J Clin Lab Invest. 1999;59:139-64.
5. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049-57.
6. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. 2002;325:1202-6.
7. Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR, Meier B, Turi ZG, Hess OM. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med. 2001;345:1593-600.
8. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJ, Eskes TK. Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae. Lancet. 1992;339:1122-3.
9. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism. 1994;43:1475-80.
10. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, Lucca U. Homocysteine, folate and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr. 2004;80:114-22.
11. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke. 2002;33:2351-6.
12. Kim MK, Ordovas JM, Selhub J, Campos H. B vitamins and plasma homocysteine concentrations in an urban and rural area of Costa Rica. J Am Coll Nutr. 2003;22:224-31.
13. Must A, Jacques PF, Rogers G, Rosenberg IH, Selhub J. Serum total homocysteine concentrations in children and adolescents: results from the Third National Health and Nutrition Examination Survey (NHANES III). J Nutr. 2003;133:2643-9.
14. Jacques PF, Rosenberg IH, Rogers G, Selhub J, Bowman BA, Gunter EW, Wright JD, Johnson CL. Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr. 1999;69:482-9.
15. Jacques PF, Bostom AG, Wilson PWF, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framinghan Offspring cohort. Am J Clin Nutr. 2001;73:613-21.
16. Malinow MR, Ducimetiere P, Luc G, Evans AE, Arveiler D, Cambien F, Upson BM. Plasma homocysteine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease. Atherosclerosis. 1996;126:27-34.
17. Hao L, Ma J, Stampfer MJ, Ren A, Tian Y, Tang Y, Willett WC, Li Z. Geographical, seasonal and gender differences in folate status among Chinese adults. J Nutr. 2003;133:3630-5.
18. Hao L, Ma J, Jianghui Zhu, Stampfer MJ, Tang Y, Willett WC, and Li Z. Vitamin B-12 deficiency is prevalent in Chinese adults aged 35 to 64 years. J Nutr. 2007;in press.
19. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong LY, et al. Prevention of neural-tube defects with folic acid in China. N Engl J Med. 1999;341:1485-90.
20. O'Broin S, Kelleher B. Microbiological assay on microtitre plates of folate in serum and red cells. J Clin Pathol. 1992;45:344-7.
21. Shin YS, Rasshofer R, Friedrich B, Endres W. Pyridoxal-5′-phosphate determination by a sensitive micromethod in human blood, urine and tissues: its relation to cystathioninuria in neuroblastoma and biliary artesia. Clin Chim Acta. 1983;127:77-85.
22. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1987;422:43-52.
23. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem. 1993;39:1764-79.
24. Ronnenberg AG, Goldman MB, Aitken IW, Xu X. Anemia and deficiencies of folate and vitamin B-6 are common and vary with season in Chinese women of childbearing age. J Nutr. 2000;130:2703-10.
25. Nygard O, Vollset SE, Rufsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland M, Kvale G. Plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 1995;274:1526-33.
26. Verhoef P, Meleady R, Daly LE, Graham IM, Robinson K, Boers GH. Homocysteine, vitamin status and risk of vascular disease. Effects of gender and menopausal status. Eur Heart J. 1999;20:1234-44.
27. Giltay EJ, Hoogeveen EK, Elbers JMH, Gooren LJ, Asscheman H, Stehouwer CD. Effects of sex steroids on plasma total homocysteine levels: a study in transsenxual males and females. J Clin Endocrinol Metab. 1998;83:550-3.
28. Kang SS, Wong PW, Cook HY, Norusis M, Messer JV. Protein-bound homocysteine. A possible risk factor for coronary heart disease. J Clin Invest. 1986;77:1482-6.
29. Masse PG, Dosy J, Cole DE, Evrovski J, Mahuren JD, Coburn SP. Elevation of plasma homocysteine in natural menopause can not be explained by a lack of vitamin coenzyme availability: relevance to the risk of cardiovascular disease. J Nutr Health Aging. 2005;9:59-64.
30. Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med. 1994;236:633-41.
31. Nygard O, Refsum H, Ueland PM, Stensvold I, Nordrehang JE, Kvale G, Vollset SE. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. Am J Clin Nutr. 1997;65:136-43.
32. Gaume V, Mougin F, Figard H, Simon-Rigaud ML. N' Guyen UN, Callier J, Kantelip JP, Berthelot A. Physical training decreases total plasma homocysteine and cysteine in middle-aged subjects. Ann Nutr Metab. 2005;49:125-31.
33. Tonstad S. Correlates of plasma total homocysteine in patients with hyperlipidaemia. Eur J Clin Invest. 1997;27:1025-9.
34. Li Z, Sun L, Zhang H, Liao Y, Wang D, Zhao B, Zhu Z, Zhao J, Ma A, et al. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a multicenter case-control study in China. Stroke. 2003;34:2085-90.
35. Wu Z, Yao C, Zhao D, Wu G, Wang W, Liu J, Zeng Z. Cardiovascular disease risk factor levels and their relations to CVD rates in China-results of Sino-MONICA project. Eur J Cardiovasc Prev Rehabil. 2004;11:275-83.
36. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, et al. Heart outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354:1567-77.
37. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354:1578-88.
38. Liem A, Reynierse-Buitenwerf GH, Zwinderman AH, Jukema JW, van Veldhuisen DJ. Secondary prevention with folic acid: effects on clinical outcomes. J Am Coll Cardiol. 2003;41:2105-13.
39. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA. 2004;291:565-75.
40. Yang Q, Botto LD, Erickson JD, Berry RJ, Sambell C, Johansen H, Friedman JM. Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation. 2006;113:1335-43.